Integrative Genomics Analysis Reveals Tissue-specific Pathways and Gene Networks for Type 1 Diabetes by Blencowe, Montgomery
UCLA
UCLA Electronic Theses and Dissertations
Title
Integrative Genomics Analysis Reveals Tissue-specific Pathways and Gene Networks for 
Type 1 Diabetes
Permalink
https://escholarship.org/uc/item/0k8488ht
Author
Blencowe, Montgomery
Publication Date
2019
 
Peer reviewed|Thesis/dissertation
eScholarship.org Powered by the California Digital Library
University of California
 UNIVERSITY OF CALIFORNIA 
Los Angeles 
 
 
Integrative Genomics Analysis Reveals Tissue-specific Pathways and Gene Networks for Type 1 
Diabetes 
 
 
 
A thesis submitted in satisfaction of the requirements for the degree Master of Science in 
Physiological Science 
 
 
by 
 
Montgomery Charles Thomas Blencowe 
 
2019 
 
 
 
 
 
 
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright by 
Montgomery Charles Thomas Blencowe 
2019 
      ii
ABSTRACT OF THE THESIS 
Integrative Genomics Analysis Reveals Tissue-specific Pathways and Gene Networks for Type 1 
Diabetes 
 
by 
Montgomery Charles Thomas Blencowe 
Master of Science in Physiological Science 
University of California, Los Angeles, 2019 
Professor Xia Yang, Chair 
Type 1 diabetes (T1D) is a complex disease, involving a genetic predisposition that interacts with 
environmental triggers, leading to the loss of insulin producing beta cells in the pancreas. However, 
the molecular cascades underlying T1D are poorly understood and remain to be explored. We 
hypothesize that genetic risk factors of T1D perturb tissue-specific biological pathways and gene 
networks, which ultimately leads to the pathogenic end point in beta cells. We sought to identify the 
gene networks and key regulators for T1D by conducting a comprehensive, data-driven multi-omics 
analysis that integrates human genome-wide association studies (GWAS) of T1D, tissue-specific 
genetic regulation of gene expression in the form of expression quantitative trait loci (eQTLs), and 
tissue-specific gene network models using a computational pipeline Mergeomics. Our integrative 
genomics approach revealed immune pathways such as adaptive immune system, cytokines and 
inflammatory response, ZAP70 translocation, primary immunodeficiency and immunoregulatory 
interactions between a lymphoid and non-lymphoid cell, across various tissues. We also identified 
tissue-specific signals such as regulation of complement cascade in adipose tissue, macrophages, and 
monocytes, NOTCH signaling in adipose tissue and macrophages, protein folding, calcium signaling, 
chemotaxis and lysosomal pathways in the pancreas, adipose, and monocytes, and viral infection in 
macrophages and monocytes. Network modelling of these pathways highlights a number of key 
regulator genes such as GBP1, USP18, STAT1, RPL17, HLA genes (HLA-A,-B,-C, and –G), and 
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immunomodulatory genes (LCK, VAV1, ZAP-70), each of which has suggestive roles in the 
pathophysiology of T1D or other autoimmune disorders. Together, our integrative genomics 
approach offers comprehensive insights into the tissue-specific molecular networks and regulators as 
well potential between-tissue interactions underlying T1D, which may guide future development of 
therapeutic strategies targeting the disease. 
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INTRODUCTION  
 
Type 1 diabetes (T1D) is characterized as the autoimmune loss of pancreatic beta cells and resultant 
impairment of glucose homeostasis. Currently, T1D accounts for 5-10% of all diabetic individuals 
worldwide, approximately 40 million cases, with an increasing incidence rate of 2-3% per year (Maahs, 
West, Lawrence, & Mayer-Davis, 2010). Risk of developing T1D is increased by ~5.6% and ~50% 
with a diseased parent or diseased monozygotic twin, respectively, when compared to the general 
population. Parental heritability estimates predict that diabetic fathers confer an increased risk of T1D 
development of about 12% while mothers at around 6% (Steck et al., 2005). Thus, there is a strong 
genetic component predisposing T1D pathogenesis. However, T1D is not usually present in 
individuals with a family history, with only ~10% of patients having a first/second-degree relative 
with the disease, and a significant environmental contribution has been highlighted (Knip & Simell, 
2012). Interestingly, there seems to be an increased disposition for developing T1D if one lives in 
regions of Northern Europe, independent of genetic background which is highlighted by an increase 
in T1D incidence in migrants living within these regions (Oilinki, Otonkoski, Ilonen, Knip, & 
Miettinen, 2012; Söderström, Åman, & Hjern, 2012). This environmental contribution has several 
potential manifestations, with alterations in gut microbiota (Kostic et al., 2015) or pre and post-natal 
dietary factors, including intake of gluten (Norris et al., 2003), vitamin D (Weets et al., 2004), and 
polyunsaturated fatty acids (Sørensen, Joner, Jenum, Eskild, & Stene, 2012) as suggested factors. 
Furthermore, a longstanding hypothesis predicts that the exposure to viral infection may also be a 
causal factor (Gamble, Kinsley, FitzGerald, Bolton, & Taylor, 1969), particular enteroviruses 
(Coppieters, Wiberg, Tracy, & von Herrath, 2012) which seem to target pancreatic islet cells (Yeung, 
Rawlinson, & Craig, 2011). Therefore, both genetic and environmental components contribute to 
T1D incidence and progression, yet a large gap exists in understanding the complex genetic and 
environmental architectures as well as the interaction between the two.  
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From the genetics perspective, with the ease and power of Genome-Wide Association Studies 
(GWAS) we have uncovered ~60 T1D genetic risk loci. The main genes predisposing T1D patients 
are located within the HLA region on chromosome 6, encoding the major histocompatibility complex 
(MHC) which is critical for adaptive immunity. While HLA-encoding genes have the strongest 
association and account for up to 50% of the total genetic T1D risk (Lambert et al., 2004; Noble et 
al., 1996), loci outside of the HLA region including protein tyrosine phosphatase, non-receptor type 
22 (PTPN22), the interleukin 2 receptor, alpha (IL2RA), insulin gene (INS) and cytotoxic T-
lymphocyte-associated protein 4 (CTLA4), have also been associated with disease development 
(Noble & Erlich, 2012).  
 
While GWAS have played an essential role in identifying T1D-associated candidate genes, typically 
only the top loci reaching genome-wide association significance of p<5e-8 are reported, and these top 
loci cannot fully explain the total genetic heritability of T1D. Identifying the missing genetic risks, or 
the “dark matter”, is important to gain a full understanding of the genetic underpinnings of T1D 
pathogenesis. In addition, growing lines of evidence support an “omnigenic” disease model (Boyle, 
Li, & Pritchard, 2017), which states that a large proportion of genes on the genome may contribute to 
disease development through intimate gene-gene interactions in networks within and between tissues, 
and key network regulators likely play more central roles than other peripheral disease genes in the 
networks. More interestingly, GWAS loci for complex diseases have been found to be more 
concentrated in the periphery of gene networks and less likely to be network regulators. Therefore, 
simply focusing on the top GWAS hits will likely miss crucial regulatory genes, and understanding 
how T1D genetic risks interact in gene networks and identifying key regulators will offer novel insights 
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into T1D pathogenesis and help prioritize regulators for targeted therapeutic strategies (Chan et al., 
2014; Chella Krishnan et al., 2018; Makinen et al., 2014; Shu et al., 2017). 
 
Integration of GWAS data with functional data such as tissue-specific expression quantitative trait loci 
(eQTLs) and gene networks has proven to be a powerful tool to pinpoint causal genes and their 
associated pathogenic mechanisms and regulators within the context of particular tissue type (Chella 
Krishnan et al., 2018; Foroughi Asl et al., 2015; Hauberg et al., 2017; Makinen et al., 2014; Shu et al., 
2017; Zhong, Yang, Kaplan, Molony, & Schadt, 2010). Our lab has previously developed a 
computational pipeline, Mergeomics, to facilitate such analysis (Shu et al., 2016). We hypothesize that 
T1D genetic risks with a wide spectrum of effect sizes (strong, moderate to subtle) interact and perturb 
tissue-specific gene networks through a select set of regulatory genes, resulting in variations in T1D 
susceptibility, and application of Mergeomics to T1D GWAS datasets in conjunction with other 
orthogonal functional genomics data will help reveal these networks and regulators. 
  
Though the integration of the largest T1D GWAS studies to date with tissue-specific functional 
information such as genetics of gene expression and gene regulatory networks, our analysis confirmed 
the importance of immune pathways across various tissues, such as adaptive immune system, 
cytokines and inflammatory response, ZAP70 translocation, primary immunodeficiency, and 
immunoregulatory interactions between a lymphoid and non-lymphoid cell. Signals demonstrating 
certain tissue specificity include regulation of complement cascade (adipose, macrophage, and 
monocytes), NOTCH signalling (adipose tissue and macrophages), chemotaxis and lysosomal 
pathways (pancreas, adipose tissue, and monocytes), and genes involved in viral infection/interferon 
signaling (macrophages and monocytes). The finding related to infection suggests a potential 
interaction between genetic predisposition and environmental perturbation. Importantly, we found 
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key genes associated with pathways that are not directly associated with immune function, such as 
spliceosome, proteasome, calcium, Wnt, and cell cycle related pathways, however they may have 
modulatory or interactive effects on the immune system within the context of T1D. Of these, we find 
cell cycle to be enriched in the pancreatic tissue which highlights the potential for tissue specific 
dysregulation of this key cellular process directly leading to a local environment which promotes beta 
cell death. These results provide us with a novel area to further explore in disease progression and 
exploit as potential therapeutic targets.	
 
MATERIALS AND METHODS 
 
Overview of study design  
We utilized an integrative genomics approach that leverages multiple large-scale human genetic and 
genomic datasets to elucidate the genetic networks and regulators of T1D pathogenesis (Figure 1). 
The datasets utilized included T1D GWAS from two independent cohorts, tissue specific eQTLs from 
diverse human tissues or cell types, various network models including gene coexpression networks, 
Bayesian gene regulatory networks and protein-protein interaction networks, and biological pathway 
information (detailed in subsequent sections). To address reproducibility, we ran the integrative 
analysis on each GWAS study independently and then focused on the findings that are consistent 
between the two cohorts. For each GWAS, we mapped the single nucleotide polymorphisms (SNPs) 
to genes using tissue/cell-specific eQTL data. The use of eQTLs helps inform on the most likely genes 
affected by GWAS SNPs based on functional evidence. Next, we grouped the genes based on whether 
they belong to the same biological pathways or show coexpression, which indicates functional 
relevance, in data-driven gene co-expression networks. We then assessed which pathways or gene 
coexpression modules (a module contains genes that show coexpression patterns) demonstrated 
      5
stronger genetic associations with T1D compared to randomly generated gene sets using a Marker Set 
Enrichment Analysis (MSEA). After carrying out the MSEA process for each T1D GWAS dataset, 
we subsequently used a Meta-MSEA to meta-analyze the two independent GWAS data sets to look 
for shared pathways/modules that showed significant T1D associations, which we further simplified 
into independent “supersets” to reduce redundancy between pathways/modules. Integrating these 
T1D supersets with gene regulatory networks (Bayesian) and protein-protein interaction networks, we 
carried out the weighted key driver analysis (wKDA) to identify key drivers (KDs), which are central 
network genes whose network neighborhoods are highly enriched for genes in the T1D pathways and 
coexpression modules. These KDs were then visualized in tissue-specific networks. Furthermore, we 
carried out in silico validation via literature mining (T-HOD, PolySearch 2.0, DisGeNET) to seek if 
these key drivers are novel, suggestive, or known to be linked with T1D (Cheng et al., 2008; Dai, Wu, 
Tsai, Pan, & Hsu, 2013; Pinero et al., 2017). 
 
T1D GWAS datasets 
The summary statistics of GWAS for T1D was obtained from the JDRF/Wellcome Diabetes and 
Inflammation Laboratory, University of Oxford (Barrett et al., 2009; Cooper et al., 2017). 
 
The study is comprised of 5913 T1D individuals of European descent (Barrett et al., 2009; Cooper et 
al., 2017), among which 3983 were genotyped using Illumina HumanHap550v3 (550k) Infinium 
Beadchip from the UK GRID and 1930 T1D individuals genotyped using Affymetrix 500K from the 
WTCCC. There were a total 8828 Controls, with 3999 genotyped using Illumina HumanHap550v3 
(550k) Infinium Beadchip from the 1958 Birth Cohort (1958BC), 1490 genotyped using Affymetrix 
500K (1958BC), 1455 genotyped using Affymetrix 500k from the UK Blood Services (UKBS) and 
1884 genotyped using Affymetrix 500K from a cohort of Bipolar disorders. 
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Inclusion criteria for the UK GRID are: T1D diagnosed between 6 months to 16 years of age, insulin 
dependent for greater than 6 months, a UK resident and self-identified as white European (average 
diagnosis age = 7.8 years of age, SD = 3.9, 47% female). Inclusion criteria for the WTCCC are: T1D 
diagnosed less than 17 years of age, insulin dependent for greater than 6 months and self-identified 
white European (average diagnosis age = 7.2 years of age, SD = 3.8, 49% female). Control inclusion 
criteria for UKBS and 1958BC included being residents in the UK and self-identified white 
Europeans. For the Bipolar cohort, control individuals greater than 16 years old and resident in the 
UK and of European descent were included.  
 
The above T1D and control individuals were partitioned into two independent cohorts based on 
matching genotyping platforms (i.e., Illumina or Affymetrix) between cases and controls. Cohort 1 
was comprised of 1930 T1D patients and 4830 Controls. Cohort 2 was comprised of 3983 T1D 
patients and 3999 Controls. 
 
SNPs genotyped were imputed to ~10 million SNPs (1000 Genomes Phase III) using IMPUTE2, and 
routine quality controls were conducted as described in Cooper et al. (Cooper et al., 2017). Statistical 
association between SNPs and T1D was carried out using a Bayesian analysis. All statistical association 
p values for all imputed SNPs that passed quality control, regardless of significance level for T1D 
association, were used in our downstream analyses. 
 
Mapping SNPs to genes 
In order to link GWAS SNPs to their potential target genes, tissue-specific eQTLs were used as they 
can provide functional insight for the role of SNPs in gene expression regulation within a given tissue. 
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Thirteen eQTLs sets were obtained from the GTEx database including subcutaneous adipose, visceral 
omentum adipose, blood, brain, colon, heart, liver, lymphocyte, muscle, pancreas, pituitary, spleen and 
stomach (Consortium, 2015). Additionally, we obtained macrophage and monocyte eQTLs from the 
Cardiogenics Consortium (Rotival et al., 2011). A broader spectrum of tissues was considered at this 
step to help objectively infer which tissues might be more informative for T1D association. GWAS 
was mapped to each tissue eQTL set separately to derive individual SNP-gene mapping sets reflecting 
tissue origins to allow assessment of tissue-specific signals. 
 
A high degree of linkage disequilibrium (LD) was observed in the eQTL data, which may cause biases 
in the downstream analysis. For this reason, we removed redundant SNPs that had LD of r2 >0.7 with 
a chosen SNP. Briefly, a GWAS SNP was compared against other SNPs for LD and T1D association. 
If the SNP was in LD of r2 >0.7 with other SNPs, the one with the strongest T1D associations was 
chosen. This process was repeated until all remaining SNPs were not in LD based on the r2 >0.7 cut-
off. These non-redundant SNPs were used for downstream analyses. 
 
Data-driven modules of co-expressed genes 
In order to assess whether T1D GWAS signals are enriched in specific gene subnetworks, we derived 
gene co-expression networks from transcriptomic data sets from genomic studies of subcutaneous 
adipose, visceral omentum adipose, blood and pancreas (Shu et al., 2016). These tissues were chosen 
due to their relevance to T1D. The WGCNA (Weighted Gene Correlation Network Analysis) package 
was used to reconstruct co-expression networks based on gene expression profiles (Langfelder & 
Horvath, 2008). Each tissue network contains multiple “modules” and each module is comprised of 
tens to hundreds or thousands of genes that show coexpression. A total of 272 co-expression modules 
were curated. 
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Knowledge-based biological pathways 
We used a total of 1827 canonical pathways from Reactome (Version 45) (Croft et al., 2014), Biocarta 
(Nishimura, 2001) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) databases (Kanehisa 
& Goto, 2000) . In addition to the knowledge-based pathways, we constructed a T1D positive control 
gene set based on candidate causal genes curated in GWAS catalog (p<5.0E-8) (MacArthur et al., 
2017). Similar control gene sets for coronary heart disease (CHD), type 2 diabetes (T2D), and height 
were also constructed to compare with the T1D positive control set. 
 
Marker Set Enrichment Analysis (MSEA) 
To identify co-expression modules and pathways that show evidence for genetic association with T1D, 
we applied MSEA from the Mergeomics (Shu et al., 2016) package on each of the GWAS cohorts 
separately in conjunction with the eQTL sources. MSEA employs a chi-square-like statistic with 
multiple quantile thresholds to assess whether a co-expression module or pathway shows enrichment 
of functional disease SNPs (i.e., those likely regulate gene expression as captured in eQTLs) compared 
to random chance. 10,000 permuted gene sets were generated for each co-expression module and 
pathway. As detailed in Shu et al., the enrichment statistics from the permutations were used to 
approximate a Gaussian distribution from which enrichment P-values were determined. Benjamini-
Hochberg (BH) false discovery rate (FDR) was estimated across all co-expression modules and 
pathways tested for each GWAS. Gene sets were considered to be statistically significant if FDR < 
5% in at least one SNP-gene mapping set. To evaluate gene sets across both GWAS studies, we 
followed up with a meta-analysis at the module/pathway level using the meta-MSEA function in 
Mergeomics, to retrieve robust gene sets across both cohorts. Stouffer’s Z score method was used to 
calculate meta P-values based on the P-values from the multiple MSEA runs. Meta-FDR was 
      9
calculated using the Benjamini-Hochberg method, as described above.     
 
Merging overlapping pathways into supersets  
The curated pathways and gene coexpression modules may carry redundant information. For example, 
a KEGG pathway “insulin signalling” can have largely overlapping genes with a Reactome pathway 
“insulin receptor signalling”. To reduce redundancy, we compared the significant modules and 
pathways associated with T1D at FDR <5% and merged the overlapping ones using a merging 
algorithm in Mergeomics to produce independent, non-overlapping “supersets”. The algorithm 
employs an overlap ratio r between two gene sets A and B as r = (rAB x rBA)0.5, where rAB is the 
proportion of genes in A that are also present in B and rBA is the proportion of genes in B which are 
also in A. The overlap ratio cut-off was set to r >= 0.33 and Fisher’s exact test was used for assessing 
the statistical significance of gene overlap between modules/pathways. BH FDR < 5% was considered 
significant. Resultant supersets containing more than 500 genes were trimmed down to contain core 
genes shared among the overlapping gene sets. 
 
Tissue-specific gene regulatory networks and key driver analysis (KDA) 
Tissue-specific Bayesian gene regulatory networks of adipose, blood, and pancreas tissue were 
obtained (Shu et al., 2016) as well as protein-protein interaction (PPI) networks obtained from the 
Human protein reference database (Keshava Prasad et al., 2008). We chose to focus on these tissue 
networks due to our MSEA results showing the strongest statistical significance for these tissues. With 
these networks, we performed a key driver analysis using a KDA algorithm in Mergeomics to identify 
potential key drivers (KDs) whose network neighbors are enriched for genes within the T1D 
associated supersets uncovered by MSEA. The algorithm employed a chi-square like statistic similar 
to that described for MSEA, and FDR < 5% was used to focus on top robust KDs. 
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In silico validation of KDs 
To determine the relevance of the top ranked KDs to T1D, we used literature-mining methods such 
as PolySearch 2.0 (Liu, Liang, & Wishart, 2015), DisGeNET (Pinero et al., 2017) and T-HOD (Dai 
et al., 2013).  
 
RESULTS 
Identification of T1D-associated knowledge-based biological pathways   
We first assessed which knowledge-based biological pathways were enriched for T1D GWAS signals. 
The use of tissue-specific eQTLs served to guide SNP-to-gene mapping, allowing us to capture tissue 
specific results. From the 15 eQTLs sets used, we found the following six to be the most informative 
in terms of whether and how many significant pathways were identified: blood, macrophage, 
monocyte, pancreas, subcutaneous adipose and visceral omentum adipose. We therefore focused on 
reporting the results from these six informative tissues only, with other tissues serving to supplement 
the main results.  
 
Out of the 1827 curated canonical pathways, we identified 224 pathways enriched from Cohort 1 at 
an FDR <5%. Of these 224 pathways, 154 were significant at FDR <5% in at least one of the six 
chosen tissues based on MSEA and the remaining 70 significant pathways passed FDR <5% when 
meta-analyzed across tissues using meta-MSEA. The top pathways enriched from Cohort 1 included 
T1D positive control group, CHD positive control, Adaptive Immune system, G-protein coupled 
receptor related processes, and positive control set for Height. In the remaining 70 pathways that 
collectively passed meta-MSEA significance across tissues, Influenza life cycle, Nuclear envelope 
breakdown and PLC-gamma-1 signalling showed top significance. From the Cohort 2 dataset we 
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found a total of 158 pathways enriched at an FDR <5%, with 129 pathways significant in at least one 
tissue in MSEA and the remaining 29 passed FDR<0.05 in meta-MSEA across tissues. The top 
pathways were confirmatory with Cohort 1, with T1D, CHD, and Height positive control sets all 
showing strong statistical significance. Additionally, Adaptive Immune system, interactions between 
lymphoid and non-lymphoid cells, ER-Phagosome pathways, Antigen processing, Wnt signaling, 
transfer in endocytosis and recycling, and SNARE interactions in vesicular transport were our top 
pathways.  
 
When comparing Cohort 1 and Cohort 2 for shared pathways, as expected we found largely 
confirmatory and overlapping pathways heavily related to immune processes and importantly the T1D 
positive control gene set. Between the two datasets we found 111 pathways significant in both, 113 
unique for Cohort 1 and 47 unique for Cohort 2 (Figure 2A). Some unique pathways for Cohort 1 
include Influenza life cycle, HIV life cycle, and nuclear envelope breakdown. For Cohort 2 the unique 
pathways included purine and inositol phosphate metabolism and RNA degradation.  
 
We found largely confirmatory results with the other tissue types tested across both Cohorts, with the 
spleen, adrenal, liver and lymphocyte revealing largely immune related signals. The pituitary gland also 
showed significance in Wnt signaling and insulin receptor signalling. 
 
Identification of T1D associated gene co-expression modules 
The above biological pathways were curated based on known knowledge. To increase the chance to 
uncover novel biology, we collected data-driven gene coexpression modules which reflect functionally 
related gene sets based on gene expression patterns. This approach has previously helped derived 
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novel biological insights into various diseases (Chella Krishnan et al., 2018; Makinen et al., 2014; Shu 
et al., 2017). 
 
From our WGCNA networks we generated 272 co-expression modules, with which we ran our 
Cohort 1 and Cohort 2 data sets independently. Cohort 1 showed enrichment in a total of 40 unique 
modules of which 36 modules passed an FDR <5% in at least one tissue and four modules were 
deemed significant collectively across the six tissues (Figure 2B). The top annotated modules for 
Cohort 1 included interferon signaling, translocation of ZAP70, Stress related pathways, 
destabilization of mRNA, focal adhesion, and diabetes pathways. On the other hand, the Cohort 2 
dataset showed significance in 46 modules (FDR <5%), with 37 significant in at least one tissue and 
9 collectively across the six tissues (Figure 2B). The top modules included cytokine signaling, 
interferon signalling, antigen processing, DNA repair, metabolism, pre-NOTCH processing in golgi, 
and Pitx2 pathway. 
 
When comparing the two cohorts we found that the majority of the modules reach significance in 
both, with a total of 30 overlapping modules. The top modules found in both were consistent with 
immune related pathways such as interferon signaling, and Antigen processing/presentation. In terms 
of unique pathways, we saw 16 unique modules for Cohort 2 including mTOR pathways, extracellular 
matrix (ECM) organization and DNA repair. In Cohort 1 we find 10 unique modules consisting of 
AKT signaling, complement pathway and ion transport (Figure 2B). 
      
Comparing these 30 overlapping modules to the 111 canonical pathways uncovered in our pathway-
based analysis, we see similar signals enriched across both. These signals include complement and 
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coagulation cascade, DNA repair, cell cycle, NOTCH signaling, metabolism of amino acids and 
derivatives, transcription, and translation.  
 
Merging of pathways and co-expression modules into independent supersets 
We chose to focus on the shared 141 significant gene sets uncovered in our meta-analysis between 
Cohort 1 and Cohort 2 (30 co-expression modules and 111 canonical pathways) as they reflect 
reproducible signals for T1D association (Figure 2A, 2B). As the co-expression modules and pathways 
were obtained from various sources, the gene sets may share a high number of overlapping gene 
members. To decrease the redundancy, we merged 83 overlapping gene sets into 12 independent 
supersets (Table 1). Interestingly, canonical pathways tend to merge with canonical pathways and 
coexpression modules tend to merge with coexpression modules, suggesting different biological 
properties of the two types of gene sets. The supersets represented diverse biological pathways 
including activation of adaptive immune system, antigen processing, ubiquitination & proteasome 
degradation, HIV infection, protein folding, RNA Polymerase I/III, mitochondrial transcription, 
signaling by GPCR, signaling by NOTCH, signaling by the B-cell receptor (BCR) and tRNA 
aminoacylation. The other 58 non-overlapping gene sets were kept intact, producing a total of 70 non-
overlapping supersets.  
 
Second round of MSEA on the 70 supersets 
After using our merging algorithm of similar pathways, we ran a second round of MSEA to confirm 
whether our merged modules retained significance for T1D association. We confirmed 40 supersets 
derived from canonical pathways to show statistical significance in our combined Cohort 1 and Cohort 
2 datasets (Figure 3A). Our results from the monocyte and macrophage-based analysis showed the 
strongest and most consistent enrichment of pathways including Natural Killer Cell mediated 
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cytotoxicity, lymphoid and non-lymphoid cell interaction, and mitotic G1/S phase. The adipose 
pathways included systemic lupus erythematosus, complement cascade, Natural Killer Cell mediated 
cytotoxicity and signaling by NOTCH. The blood tissue-derived pathways contained ABC 
transporters, Antigen processing and presentation, Secretin receptors, cell cycle and neuroactive 
ligand-receptor interaction. The pancreas showed pathways involved in Natural Killer Cell mediated 
cytotoxicity, secretin receptors, protein folding, calcium signaling and Wnt signaling. When looking at 
the remaining 30 supersets derived from our co-expression modules (Figure 3B). Again, monocyte 
and macrophage were informative across most of the listed supersets (Figure 3B). Pancreas and 
subcutaneous adipose tissue were also informative for 14 and 25, respectively, of the 30 supersets 
(FDR <5%). The blood appeared to be the least informative for these supersets, with only a few 
supersets related to DNA replication, interferon signaling, mitotic cell cycle, and TCR signalling being 
significant. Across all six tissues we found that translocation of ZAP70, calcium signaling, interferon 
signalling, and Stress pathways were significant.  
 
Identification of central regulators for T1D via a weighted key driver analysis 
To identify central regulatory genes, or key drivers (KDs), among the potential T1D associated 
supersets, we performed a weighted key driver analysis (wKDA) on our independent supersets using 
tissue-specific Bayesian gene regulatory networks as well as using the PPI networks (Figure 4).  
 
The total number of unique KDs found from our Bayesian network included 299 across blood, 
monocyte, macrophage, adipose and pancreatic islet networks at an FDR <5% (Supplement Table). 
To focus on the most central regulators, for each superset in each tissue-specific network, we chose 
the top five ranked KDs satisfying an FDR <5%, to derive 60 KDs, of which 13 were shared among 
>=2 supersets and two (RPS29 and RPS18) were shared across the adipose, blood, monocyte and 
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macrophage networks. In terms of tissue specific KDs we found that the adipose network contained 
the most with 45 KDs, and 13 unique KDs were shared between blood, monocyte and macrophage 
networks (Supplement Table). There were no KDs discovered for our pancreatic tissue Bayesian 
network, potentially due to the sparseness of this network. The key drivers uncovered can generally 
be categorized under cell cycle, metabolism and immune related pathways. Interestingly, many of the 
KDs have been found to be involved in viral infections, autoimmune and childhood onset disease, all 
of which are associated with T1D. These KDs include RPS29, RPLP2, CD19, OAS2, IFIH1 and 
PTPN6. 
 
To expand our search for KDs and look for consistencies between networks, we ran the PPI network 
for adipose, blood, monocyte. macrophage and pancreatic tissues. Focusing on the top five ranked 
KDs in each tissue specific network within each superset, we found a total of 113 KDs, five specific 
to adipose (CASP9, FLNA, BRF1, CD74, HLA-DRA), three specific to blood (PTPRC, MYC, 
GNA11), one for the pancreas (JAK1), two for monocyte (AKT1, ESR1) and two for macrophage 
(POLR2G, PROS1). 
 
When comparing the PPI network with the Bayesian network we find 17 overlapping KDs for tissue 
specific networks (15 for adipose, two for blood) including complement related genes such as CD19 
and CD74, DNA replication genes such as MCM2 and MCM6, as well as those linked to autoimmunity 
such as STAT1, SERPINE1 and GZMB. Those shared in the Top 5 KDs (FDR <5%) of the same 
supersets for both the Bayesian and PPI networks include LCK, VAV1, PTPN6 for Natural Killer 
Cell Cytotoxicity and F2 and PLG for Complement and Coagulation pathways (Table 2). 
 
In silico validation of the Key Drivers  
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To determine the relevance and functional significance of the unique KDs from our Bayesian and PPI 
network analysis to T1D from our study, we cross-validated the genes by performing a comprehensive 
in silico analysis using three literature mining methods: PolySearch 2.0, DisGeNET, and T-HOD. 
  
Our search yielded 6 KDs that are known T1D GWAS hits (HLA-DRB1, IFIH1, PGM1, HLA-DQB1, 
HLA-B and HLA-DRA) as well as 43 KDs such as GC, PLG, LCK, STAT1 and PPARG which were 
suggested to be associated with T1D due to previously being implicated in one or more studies to play 
a potential role in T1D pathogenesis.  
 
Our study further uncovered a total of 107 potential novel KDs for T1D, many of which have viral 
infection associations (OAS2, IFIH1, ISG15, SLC15A3 and RTP4). Additionally, we find large overlap 
of KDs with genes previously associated with autoimmune diseases such as Lupus Erythematosus, 
Psoriasis and Rheumatoid Arthritis (PTPN6, MCM2, LCK, OAS2 and CD3G). 
 
DISCUSSION 
At present, genetic studies have uncovered >60 loci linked with T1D development, yet our 
understanding of the intricate mechanisms underlying these associations is still lacking. In addition, 
GWAS loci alone cannot provide the level of insights required for intervention. To this end, we utilised 
a multi-omics integrative approach to advance our understanding of T1D etiology and prioritize 
potential therapeutic targets among the large numbers of disease associated signals. Through the use 
of multiple T1D GWAS data sets, functional genomics data represented as tissue-specific eQTLs, 
knowledge-driven pathways, and data-driven networks, the perturbed pathways and key regulators 
which potentially drive the etiology of T1D were further elucidated.  
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This computational strategy confirmed known genes and biological pathways in T1D and revealed 
novel genes and their corresponding networks and biological processes. Among the biological 
networks which are perturbed to initiate or exacerbate T1D, are a significant number of immune and 
apoptosis related processes which are known to be involved in T1D, and several novel pathways such 
as viral infection, NOTCH signaling, Wnt signaling, protein folding, and calcium signaling. Our tissue 
specific analyses reveal consistent enrichment of antigen processing/presentation and INF-α/β/γ 
signalling across tissues, supporting the immune origin of T1D highlighted in the literature and 
emphasizing the presence of systemic dysregulation of immune function beyond insulitis. For the 
multi-tissue immune pathways for T1D, top KDs predicted by our analyses are HLA-DR/DQ alleles 
(Hu et al., 2015). Although HLA genes have been known to confer the greatest genetic risk for T1D, 
our network analysis uniquely highlights the critical regulatory roles of these genes in T1D 
development.  
 
Of the immune related pathways, a notable process which shows perturbation in macrophage and 
monocyte is ubiquitination and proteasome degradation within the context of Class I MHC mediated 
antigen processing. Many of the key drivers which were highlighted in our analysis relate directly to 
the immunoproteasome and the maturation of the MHC I complexes, including GBP1 (Lundberg, 
Krogvold, Kuric, Dahl-Jorgensen, & Skog, 2016), PSMA6 (Sjakste et al., 2016) , and PSMA4 (Jin et 
al., 2013), each of which have been previously implicated in T1D susceptibility. Additionally we 
identified several HLA genes, including HLA-A, -B (Nejentsev et al., 2007), -C (Genetic Analysis of 
Psoriasis et al., 2010), and -G (Eike, Becker, Humphreys, Olsson, & Lie, 2009), which have been 
previously associated with T1D or autoimmune disease susceptibility. Dysregulation of the MHC class 
I binding peptides produced by the cytosolic multicatalytic proteasome may play a fundamental role 
in the development of T1D causing autoimmunity. These MHC class I molecules are a major inducer 
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of the host immune response and alterations in MHC I peptide presentation have a putative role in 
autoimmune pathogenesis, with links to ankylosing spondylitis (Evans et al., 2011), multiple sclerosis 
(Guerini et al., 2012), and Crohn’s disease (Barrett et al., 2008). Previous evidence also supports the 
role of the immunoproteasome in the induction of T1D through the generation of aberrant 
polypeptide derived epitopes which act as β-cell neo-autoantigens (Thomaidou, Zaldumbide, & Roep, 
2018), which is another potential avenue of disease development.	
 
Furthermore, a number of the identified KDs relate to the modulation of immune response and 
autoimmunity, most notably IFIH1, a DEAD box RNA helicase which has been linked to T1D 
susceptibility. Additionally, we identify JAK1 via our PPI KDA, which has previously been shown to 
regulate pediatric autoimmunity and local inflammatory response via its interactions with STAT and 
INF signaling, thus acting as an intriguing target for further study. Moreover, the inhibition of JAK1 
levels via AZD1480 blocked MHC class I upregulation via cytokine signaling within both mouse and 
human beta cells (Trivedi et al., 2017). Through this, the infiltration of immune cells into the pancreatic 
islets was dramatically slowed, as the T cells were no longer able to directly associate with beta cells, 
protecting NOD mice from insulitis. These results affirm the previous predictions made regarding the 
etiology of T1D, with significant emphasis on the failure of the immune system to recognize beta cell 
autoantigens as self, thus resulting in the destruction of these cells. Our results here further emphasize 
the potential of these immune related genes as central regulators and targets to ameliorate the 
pathogenesis of T1D.  
 
Our results also support the importance of T cells and cytokine signalling in T1D pathogenesis. FYN 
(Figure 4A) is one of the most central key regulators in the T1D tissue networks and is connected a 
number of previously identified T1D associated GWAS loci (IL7R, MAPT, TYK2). Importantly, this 
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gene has been shown to be essential in T cell signaling and related processes, through its interaction 
with ZAP-70 (Michel, Grimaud, Tuosto, & Acuto, 1998) and VAV1 (Garcia-Bernal et al., 2005), 
which are both key components of T cell mediated immune response and have been identified as key 
drivers in our network analysis. The role of T-cell signaling and autoimmunity within the context of 
T1D progression is further highlighted by KD LCK (Stanley, Trivedi, Sutherland, Thomas, & Gurzov, 
2017), which has also been previously shown to preclude autoimmunity through its interaction with 
DUSP22, serving as a negative regulator of T-cell activation. Also, the KDA identifies PTPN6, which 
has been shown to modulate cytokine signaling within pancreatic beta cells, in coordination with the 
action of PTPN1 to connect the beta cells with the immune system. Finally, several other KDs were 
noted using the Bayesian network blood tissue data, including SEMA4A (Chapoval, Vadasz, 
Chapoval, & Toubi, 2017) and TCF7 (Noble et al., 2003) . SEMA4, coding for Semaphorin 4A, has 
been shown to play a role in a number of autoimmune diseases including multiple sclerosis, Systemic 
lupus erythematosus, and Rheumatoid arthritis through its action in activating regulatory T cells 
(Delgoffe et al., 2013). Furthermore, it may have a potential role in inhibiting angiogenesis which may 
further perpetuate the T1D disease progression (Toyofuku et al., 2007). Similarly, polymorphisms 
within TCF7, a T cell transcription factor, have also been identified as being associated with T1D and 
may be an essential locus in the etiology of T1D through its downstream action of modulating immune 
response. Our analysis thus provides confirmation for the importance of T cell genes and pathways, 
as well as pinpointing the essential regulators to explore further within the context of T1D. 
 
More globally, we identified several pathways which imply a pathogenic change in the molecular 
machinery coordinating protein production and processing, including spliceosome, mRNA 
metabolism, tRNA aminoacylation, gene expression, translation, and proteasome in our meta-MSEA. 
Kracht et al. reported that the production of a non-conventional products due to mRNA processing 
errors produces an autoimmune polypeptide that is detected by T cells in T1D patients (Kracht et al., 
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2017). It is also predicted that the formation of hybrid insulin peptides within beta cells activates CD4 
T cells in NOD mice (Delong et al., 2016), thus further supporting the association between T1D and 
the failure of proteins to be processed correctly. It is plausible that variations within genes governing 
protein formation and processing components induce antigenic protein products within the pancreatic 
tissue itself or within immune cells, which results in the activation of an autoimmune response, beta 
cell death, and development of T1D.		
Viral infection (Allen, Kim, Rawlinson, & Craig, 2018) and its association with T1D has been 
suggestive as the potential causal environmental trigger, particularly with regard to antenatal maternal 
infection and subsequent incidence of T1D. In support of this theory we found a number of pathways 
associated with HIV and influenza virus infection across multiple tissues tested. Given that these 
pathways are genetically perturbed as informed by our T1D GWAS datasets, our finding implies that 
genetic variants in genes involved in viral infection may confer vulnerability to infections and/or 
promote over-reactive viral response that induces autoimmunity, which explains how viral infection 
may trigger T1D pathogenesis. We have identified several KDs which may be susceptible to viral 
perturbation resulting in modulation of immune response, which includes PSMA7 (Apcher et al., 
2003), TRAF6 (Yoboua, Martel, Duval, Mukawera, & Grandvaux, 2010), CD3G (Willard-Gallo, 
Furtado, Burny, & Wolinsky, 2001) , PIK3R2 (Ylosmaki, Schmotz, Ylosmaki, & Saksela, 2015), and 
MCM6 (Gautier et al., 2009). Of these, proteasomal alpha subunit PSMA7 enables the human 
immunodeficiency virus-1 (HIV-1) Tat protein to disrupt proteasome function through its interaction 
with the subunit, thus highlighting a potential region which is susceptible to viral modulation (Apcher 
et al., 2003). The association with this protein and potential T1D pathogenesis goes further as it may 
modulate both cellular stress response (Li, Zhang, Zhang, & Wei, 2011) and antigen processing (Du 
et al., 2009), which may collectively impact beta cell survivability. Also, TRAF6, a TNF receptor, has 
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been previously shown to modulate viral load in hepatitis C virus patients (Pu et al., 2017) as well as 
the immunogenic inflammatory response in dengue virus infected patients (Motaleb, Nabih, 
Mohamed, & Elhalim, 2017), thus serving as a connection between viral infection and immune 
response (Fang et al., 2017). Additionally, there is evidence suggesting that viral infection alters the 
expression and local chromatin landscape of the T cell receptor complex subunit CD3G (Akl et al., 
2007; H. Yu et al., 2015), with further reports associating this subunit with autoimmunity (Tokgoz et 
al., 2013). The other two predicted key driver genes, MCM6 (Tan et al., 2017) and PIK3R2 (Kim, 
Hollenbaugh, Kim, & Kim, 2011) are predicted to influence antiviral and inflammatory response after 
viral infection.  
      
Another immune-related pathway is the SNARE interaction with vesicular transport pathway 
(Offenhauser et al., 2011), which is significant in that the protein complex seems to act as a negative 
regulator of macrophage activity and is associated with familial hemophagocytic lymphohistiocytosis 
type 4 (FHL-4) (zur Stadt et al., 2005), a hyper-inflammatory disease. Moreover, SNARE also regulates 
cross presentation of antigens within dendritic cells through the action of Sec22b (Cebrian et al., 2011) 
which enables the delivery of antigens from the phagosome into the  cytosol, thus further 
corroborating this complex’s role within immune response.  
 
Further, we identify NOTCH signaling as a potential contributor to T1D, which has been implicated 
in rheumatoid arthritis (Yabe, Matsumoto, Tsurumoto, & Shindo, 2005), another proposed 
autoimmune disease. There is evidence that Notch receptors are constitutively expressed on 
macrophages and dendritic cells, thus play a direct role in immunity (Zhang et al., 2012). NOTCH 
signaling has also been identified within the context of viral response (Ito et al., 2011), with its signal 
integral in influenza pathogenesis. These previous results highlight the integral role Notch signals play 
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within many of the proposed mechanisms of T1D initiation, thus our predictions serve as further 
evidence of this mechanism as a potentiation route to explore further mechanistically and 
therapeutically. Our KDA results also support this finding, with NOTCH1, 2, 3, and 4 all arising as 
significant KDs within blood, adipose, macrophage, and monocyte tissue/cell types. Furthermore, in 
a recent publication by Bartolome et al., chronic NOTCH activation is shown to impair beta cell 
function through a loss of maturity combined with increased proliferation rate during T2D related 
physiological stress (Bartolome, Zhu, Sussel, & Pajvani, 2018). Our results suggest that this may also 
contribute to the loss of beta cells function throughout T1D disease progression. 
 
Finally, we highlight calcium signaling as a perturbed pathway in the pancreatic tissue. Dysregulation 
of this signaling process has been previously identified as a pathogenic mechanism in acute pancreatitis 
(Frick, 2012) and its perturbation is generally predicted to play a significant role in apoptotic pathways 
(Orrenius, Zhivotovsky, & Nicotera, 2003). Moreover, this pathway was identified within the 
macrophage and blood tissues which may further link calcium signaling and immune dysfunction. 
Previous reports show that modulation of the calcium signal transducer, calmodulin, mitigates the 
development of systemic lupus erythematosus in mice and suppresses INFγ production in human 
SLE cells (Ichinose, Juang, Crispín, Kis-Toth, & Tsokos, 2011). Furthermore, calcium alters B cell 
reactivity and anergy, thus critically regulating the development of autoreactivity (Bouillet et al., 1999) 
and inflammatory response (P. Yu et al., 2005). Interestingly, the B cell adaptor protein CD19  which 
integrates calcium signalling and B cell mediated immunity (Tedder, Haas, & Poe, 2002), was identified 
as a KD within the blood tissue, which has a protective role in slowing the decline in beta cell function 
within T1D models (Vonberg et al., 2018). 
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Overall, our integrative genomics analysis recapitulates previously known pathways, processes and 
genes associated with T1D pathogenesis, primarily components of the immune system, confirming 
the robustness of our study. We additionally uncover possible avenues to explore further with 
suggested pathways and key genes involving the pancreas to be potentially contributing significantly 
to the T1D outcome through genetic perturbations, including those that can interact with 
environmental factors such as viral infections. The KDs prioritized through our comprehensive 
integrative analyses may serve as putative T1D targets for therapeutic development. Future efforts to 
validate the predicted novel regulators and pathways are warranted. 
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Table 1. Top pathways associated with T1D identified across multiple tissues at an FDR <5%. 
Blood: 1, Macrophage: 2, Monocyte: 3, Pancreas: 4, Subcutaneous Adipose: 5 and Visceral Omentum 
Adipose: 6. 
Supersets Module 
Size 
Tissues Pathways 
T1D positive control 60 1, 2, 3, 4, 5, 6 Positive control gene set for T1DM 
S1:  
Mitotic G1-G1/S 
phases 
  
186 1, 2, 3, 5, 6 
  
Mitotic G1-G1/S phases; Cell Cycle Checkpoints and 
Regulation; DNA Replication; Vpu mediated degradation of 
CD4; Disease; Antigen Processing-Cross presentation 
  
S2: HIV Infection 222 2, 3 HIV Infection; Host Interactions of HIV factors 
S3: Signaling by 
NOTCH 
122 3, 5, 6 Signaling by NOTCH 
Pre-NOTCH Expression and Processing 
S4: Protein folding 53 3, 4, 5 Protein folding; Chaperon-mediated protein folding; 
Association of TriC/CCT with target proteins during 
biosynthesis 
S5:  Signaling by B 
Cell Receptor (BCR) 
170 2, 3 Signaling by the B Cell Receptor (BCR); Downstream 
Signaling Events of B Cell Receptor (BCR) 
S6:  RNA Polymerase 
I, RNA Polymerase 
III, and Mitochondrial 
Transcription 
95 3, 5 RNA Polymerase I, RNA Polymerase III, and Mitochondrial 
Transcription; RNA Polymerase I Transcription; RNA 
Polymerase I Promoter Clearance; RNA Polymerase I Chain 
Elongation 
S7:  Antigen 
processing: 
Ubiquitination & 
Proteasome 
degradation 
211 2, 3 Antigen processing: Ubiquitination & Proteasome 
degradation; Class I MHC mediated antigen processing & 
presentation 
S8:  Adaptive 
Immune System 
261 2, 3 Adaptive Immune System; Immune System 
S9: tRNA 
Aminoacylation 
46 2, 3, 5 tRNA Aminoacylation; Aminoacyl-tRNA biosynthesis; 
Mitochondrial tRNA aminoacylation 
S10:  Mitotic M-
M/G1 phases 
172 2, 3 Mitotic M-M/G1 phases; Mitotic Metaphase and Anaphase; 
Cell Cycle; Cell Cycle, Mitotic; M Phase; Mitotic Anaphase; 
Separation of Sister Chromatids 
S11: Signaling by 
GPCR 
230 3 Signaling by GPCR; GPCR downstream signaling  
GPCR ligand binding 
S12: Activation of 
GABAB receptors 
39 3 Activation of GABAB receptors; Activation of GABA B 
receptors 
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Table 2. T1D genetic supersets with KDs for both Bayesian and PPI networks.  Only supersets with at least one KD (FDR <5%) were 
shown. For supersets with more than five KDs, only the top 5 KDs are shown. 
 
 
Supersets 
Bayesian Network PPI Network 
Adipose Blood Adipose Blood Pancreas 
Metabolism of mRNA RPL31, FAU, RPS29, 
RPS18, RPS27 
 
RPL38, RPS29, RPL7A, 
RPLP2, RPL7 
 
UPF2, EXOSC6, NDRG1, 
EXOSC8, EXOSC4 
 
UPF2, EXOSC6, NDRG1, 
EXOSC8, EXOSC4 
 
 
Signal Transduction BC052328, LGMN, 
EMR1, EVI2B, SLC15A3   
DOK1, PIK3R2, MMP9, 
GNAI2, CCR5     
Gene Expression RPL31, RPS29, RPS18, 
RPS27, FAU   
NCOA6, RXRG, NR0B2, 
PPARGC1A, MED1     
Systemic Lupus 
Erythematosus  
HIST1H2BM, 
HIST1H2BC   PTMA PTMA, ASF1A   
Mitotic M-M/G1 
phases 
RAD51, MCM2, CDCA8, 
MKI67, FIGNL1   
CDK2, PLK1, PCNA, 
CDKN1A, MCM7 
CDK2, PLK1, PCNA, 
CDKN1A, MCM7   
Natural Kill Cell 
Cytoxicity  
PTPN6, FERMT3, 
ARHGAP30, NCKAP1L, 
LCK 
  LCK, SHC1, SYK, PTPN6, VAV1 
LCK, SHC1, SYK, PTPN6, 
VAV1 
LCK, SHC1, SYK, 
PTPN6, VAV1 
RNA Polymerase I, 
RNA Polymerase III, 
and Mitochondrial 
Transcription 
HIST1H2BM, 
HIST1H2BC   
TBP, ERCC3, CDK7, RB1, 
BRF1     
Complement & 
Coagulation  
F2, FGG, PLG, AHSG, 
GC   F2, SERPINA5, PLG, C3, F10 
F2, SERPINA5, PLG, C3, 
F10   
Disease RPS18, RPL27, MYO1F, 
ACTR3, FAU   
PIK3R2, FGFR1, ERBB4, 
NOTCH1, STAT5B 
PIK3R2, FGFR1, ERBB4, 
NOTCH1, STAT5B   
Immunoregulatory 
interactions between a 
Lymphoid and a non- 
Lymphoid cell 
 
CD3G, LCK   HLA-C, HLA-G, CD3D, HLA-B, ITGA4 
HLA-C, HLA-G, CD3D, 
HLA-B, ITGA4   
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Figure 1. Overview of Study. 1) T1D GWAS SNPs are mapped onto genes using tissue specific 
eQTLs. Genes found are then linked to canonical pathways and co-expression modules. 2) MSEA of 
Cohort 1 and Cohort 2 are carried out independently for pathway/co-expression module enrichment. 
3) Meta-MSEA of the combined cohorts for pathway/co-expression module enrichment. Similar 
modules are then categorized into independent supersets and input into a wKDA. 4) wKDA 
implemented using both protein-protein interaction (PPI) and Bayesian networks independently for 
key driver gene identification, followed by in silico validation.
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Figure 2. Venn Diagram of enriched canonical pathways and co-expression modules for both 
T1D GWAS cohorts. A) Venn diagram of the independent and overlapping knowledge driven 
biological pathways for both cohorts (FDR <5%). B) Venn diagram of the independent and 
overlapping co-expression modules for both cohorts (FDR <5%). 
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Figure 3. Heatmap of the tissue-specific meta-MSEA from the combined Cohort 1 and Cohort 
2 datasets for the supersets derived from the canonical pathways and co-expression network 
modules. A) Heatmap for the statistical significance of T1D genetic association across the supersets 
derived from the Canonical pathways (FDR <5%) in the tissue-specific and cross-tissue analyses. B) 
Heatmap for the statistical significance of T1D genetic association across the supersets derived co-
expression modules (FDR <5%) in the tissue-specific and cross-tissue analyses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      30
A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      31
B 
 
 
 
 
 
      32
 
 
C 
 
 
 
 
 
 
 
 
 
Figure 3. Tissue specific Key Driver Subnetworks. A) Pancreas PPI network. B) Blood Bayesian 
Network. C) Adipose Bayesian Network. 
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